Presentation Title

The Utility of Gadolinium Contrast Agents in Older Multiple Sclerosis Patients not on Disease Modifying Therapy

Presenter's Name(s)

Liam du PreezFollow

Abstract

Multiple sclerosis (MS) is an autoimmune disease defined by the presence of multiple foci of white matter inflammation and demyelination in the central nervous system (CNS). Contrast-enhanced magnetic resonance imaging (MRI) is a crucial tool in assessing and monitoring disease activity in patients with this condition. This retrospective observational study aims to assess the outcomes and thus utility of contrast-enhanced imaging in older patients that have stopped Disease Modifying Therapy (DMT).

Primary Faculty Mentor Name

Adam Ulano, MD

Status

Medical Students

Student College

Larner College of Medicine

Program/Major

Health Sciences

Primary Research Category

Health Sciences

This document is currently not available here.

Share

COinS
 

The Utility of Gadolinium Contrast Agents in Older Multiple Sclerosis Patients not on Disease Modifying Therapy

Multiple sclerosis (MS) is an autoimmune disease defined by the presence of multiple foci of white matter inflammation and demyelination in the central nervous system (CNS). Contrast-enhanced magnetic resonance imaging (MRI) is a crucial tool in assessing and monitoring disease activity in patients with this condition. This retrospective observational study aims to assess the outcomes and thus utility of contrast-enhanced imaging in older patients that have stopped Disease Modifying Therapy (DMT).